EFTA00314043.pdf

sa/LId10 lbtsw From: Woodson C. Merrell M Uebfax Page: 6/11 ILabCorp Patient Report Panto 14172111.**FILIY !x14:01/20/1953 Patient ID: 5paimenrO: 25740043714 Control ID: f S831, 43092 Data collated: 09/14/201/ 1255 Local TESTS RESULT FLAG UNITS REFERENCE INTERVAL 'L AB Dna-Sulfate 181.8 ug/dL 30.9 - 295.6 01 Estradiol 28.3 pg/mL 7.6 - 42.6 Roche ECLIA methodology 01 Uric Acid Uric Acid 6.8 mg/dL 3.7 - 8.6 Please Nbter 01 Therapeutic target for gout patients: 01 <6.0 Phosphorus 3.6 mg/dL 2.5 - 4.5 01 LDS 213 IU/L 121 - 224 01 GOT 25 IU/L 0 - 65 01 Amylase 37 U/L 31 - 124 01 Ferritin, Serum Kill Follow Insulin 47.2 Nigh uIU/mL 2.6 - 24.9 01 Calcium, Ionised, Serum 5.3 4.5 - 5.6 mg/dL 01 Fibrinogen Activity 330 mg/dL 193 - 507 01 Specimen was ultracentrifuged before testing to remove extreme 'Spezia. Results should be interpreted with caution. Magnesium, ESC 5.4 Plasma NOT separated from cells; may mg/dL 4.2 - 6.8 02 falsely decrease ABC Magnesium levels. 0t RN Soap Radian Dr Aracei B Reyes, IC 89 For Avenuo. Reckon, NJ 08889.1800 02 BN WC*" BurtOl9930 Ur: Wiam F Hancock. MD 1447 York NC 27215-3381 For irgairles. sa 01100100 rnaY end en Date 'Mad: 09/18/113 1053 ET PRELIMINARY REPORT This document contairsprrate al/ cordeentialNab Sontato Page 5 af n pound t7 state and Wang taw. o 1995-zns Spate, Corpaddon of Hadar Holdlegs IIyouIse reotred this /meanIn am. pies am 800431.3250 Alaphis kswwd -Erns* Repollierilort 1/0 EFTA00314043